Ian M. Rosenthal

Johns Hopkins University — United States

Medicine · Health Sciences

14h-index1.7kcitations20works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(15), Cancer therapeutics and mechanisms(8), Pneumonia and Respiratory Infections(4), Pneumocystis jirovecii pneumonia detection and treatment(4), Mycobacterium research and diagnosis(3)

Publications20 total

Noninflammatory comedones have greater diversity in microbiome and are more prone to biofilm formation than inflammatory lesions of acne vulgaris
International Journal of Dermatology·2020· 13 cited
Noninflammatory comedones have greater diversity in microbiome and are more prone to biofilm formation than inflammatory lesions of acne vulgaris
Zenodo (CERN European Organization for Nuclear Research)·2020Open Access
A unique telomere DNA expansion phenotype in human retinal rod photoreceptors associated with aging and disease
Brain Pathology·2018· 5 citedOpen Access
Dermatofibrosarcoma Protuberans-Like Tumor With COL1A1 Copy Number Gain in the Absence of t(17;22)
American Journal of Dermatopathology·2016· 14 citedOpen Access
Reply to “Contradictory Results with High-Dosage Rifamycin in Mice and Humans”
Antimicrobial Agents and Chemotherapy·2013· 3 citedOpen Access
A Case of Infraorbital Lichen Sclerosus
Dermatology Online Journal·2013· 11 citedOpen Access
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
Antimicrobial Agents and Chemotherapy·2012· 160 citedOpen Access
Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice
American Journal of Respiratory and Critical Care Medicine·2011· 57 citedOpen Access
Failure Of Daily Treatment For Tuberculosis (TB) With Rifampin (R), Isoniazid (H) And Pyrazinamide (Z) In Immune-deficient Mice
2010· 1 cited
Short-Course Therapy with Daily Rifapentine in a Murine Model of Latent Tuberculosis Infection
American Journal of Respiratory and Critical Care Medicine·2009· 72 citedOpen Access
Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
Antimicrobial Agents and Chemotherapy·2009· 94 citedOpen Access
Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?
American Journal of Respiratory and Critical Care Medicine·2008· 65 citedOpen Access
Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
Antimicrobial Agents and Chemotherapy·2008· 198 citedOpen Access
Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine Model
PLoS Medicine·2007· 211 citedOpen Access
Combination Chemotherapy with the Nitroimidazopyran PA-824 and First-Line Drugs in a Murine Model of Tuberculosis
Antimicrobial Agents and Chemotherapy·2006· 119 citedOpen Access
Potent Twice-Weekly Rifapentine-containing Regimens in Murine Tuberculosis
American Journal of Respiratory and Critical Care Medicine·2006· 89 citedOpen Access
Rifapentine, Moxifloxacin, or DNA Vaccine Improves Treatment of Latent Tuberculosis in a Mouse Model
American Journal of Respiratory and Critical Care Medicine·2005· 69 citedOpen Access
Weekly Moxifloxacin and Rifapentine Is More Active Than the Denver Regimen in Murine Tuberculosis
American Journal of Respiratory and Critical Care Medicine·2005· 54 citedOpen Access
Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of Tuberculosis
Antimicrobial Agents and Chemotherapy·2005· 220 citedOpen Access
Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis
American Journal of Respiratory and Critical Care Medicine·2004· 221 cited

Frequent Co-authors

J Grosset(15), Sandeep Tyagi(9), Kathy N. Williams(9), Eric L. Nuermberger(9), Charles A. Peloquin(9), William R. Bishai(7), Eric Nuermberger(6), Ming Zhang(6), Deepak V. Almeida(6), Andrew Vernon(4), Rokeya Tasneen(4), Tetsuyuki Yoshimatsu(2), Richard E. Chaisson(2), Khisimuzi Mdluli(2), Petros C. Karakousis(2), Manisha J. Loss(2), Katherine G. Thompson(2), Alessandra Agostinho‐Hunt(2), Garth A. James(2), Emmanuel F. Mongodin(2)